New University of Michigan Tinnitus Discovery — Signal Timing
- Thread starter Hudson
- Start date
Member
It's not. It's linked from a UMich newsletter I just received on May 29th. The email stated the following:
The post on their LinkedIn describes them as a "licensee of bimodal patents" to a number of companies. I imagine this has been discussed before, but it suggests to me that instead of developing its own products entirely in-house, the company is licensing these patents to others who are working on devices aimed at the same goals as the Susan Shore device and its underlying research.
To me, this means that multiple firms may be developing similar tools or treatments, which could increase the chances of effective solutions reaching the market. Since the patent licensing covers such a broad range, it may also explain why it is difficult to get specific information directly from Auricle.
Again, this has likely been mentioned before, but in my view, it is encouraging. It suggests that other companies are also working toward the same goal of effective treatment.
To me, this means that multiple firms may be developing similar tools or treatments, which could increase the chances of effective solutions reaching the market. Since the patent licensing covers such a broad range, it may also explain why it is difficult to get specific information directly from Auricle.
Again, this has likely been mentioned before, but in my view, it is encouraging. It suggests that other companies are also working toward the same goal of effective treatment.
Log in or register to get the full forum benefits!
Similar threads
